Stocks to Watch Today, 5th March 2025: Coforge, Biocon, Adani Wilmar, RVNL, and more

Indian stock markets ignore Donald Trump’s tariff concerns and continue on a gradual recovery journey. Sensex and Nifty, opened on a positive note today. The Sensex gained 153 points or 0.21%, opening at 73,143.81. Similarly, the Nifty opened higher at 22,141.40, up 58.75 points or 0.27%.

Key Stocks in Focus

Coforge: Announces first-ever stock split, board approves subdivision of each equity share face value of ₹10 into five equity shares of face value of ₹2 each. Coforge has also signed a landmark 13-year strategic partnership agreement worth USD 1.56 billion with Sabre Corp. to drive product innovation and delivery.

Biocon: Biocon in the biotech space has secured the final nod from USFDA for its Lenalidomide capsules in multiple strengths. Used to treat multiple myeloma, lymphoma and myelodysplastic syndromes. In addition, Biocon Pharma, an affiliate, has obtained USFDA approvals for Dasatinib tablets and a tentative clearance for Rivaroxaban tablets.

Adani Wilmar: A leading FMCG player has signed a definitive agreement to buy GD Foods Manufacturing, which owns the popular 'Tops' brand. The deal will be completed in phases, with at first Adani Wilmar set to take an 80% stake, while 20% stake will be taken over the next three years.

Jio Financial Services & SBI: The State Bank of India will sell its 17.83% stake in Jio Payments Bank to Jio Financial Services for ₹104.54 crore. This will make Jio Payments Bank a 100% owned subsidiary of Jio Financial Services after this transaction. The acquisition, which is still subject to approval from the Reserve Bank of India, is likely to be completed within 45 days from the date of the clearance.

Ola Electric: Public sector lender IFCI Ltd has issued a notice to electric vehicle maker Ola Electric on failure to achieve its first milestone as part of the Manufacturing Linked Incentive (PLI) Advanced Chemistry Cell scheme. The company also admitted to not meeting the targets set out in the deal made in July 2022, and they are in discussions with the authorities.

Apollo Hospitals: Plans have been announced to further expand the proton therapy capacity at Apollo Hospitals with a ₹250 crore investment in a complete oncology centre in Hyderabad in addition to launching similar facilities in other parts of the country. This facility is expected to be operational by fiscal year 2028 and will serve for the first time in India, the Proteus One proton system.

Power Grid: The three inter-state transmission system projects have been awarded to Power Grid Corporation, a government-owned company, through the tariff-based competitive bidding mode. These projects will be implemented on a Build, Own, Operate, and Transfer (BOOT) basis. 

GE Vernova: GE Vernova T&D India has secured orders worth ₹500 crore from Power Grid for the supply and installation of 765kV class transformers and reactors under a bulk procurement agreement.

Grasim Industries: Part of the Aditya Birla Group, has started commercial production at its Birla Opus Paints plant in Mahad, Maharashtra. Installed capacity of the facility is 230mn litres per annum and manufactures a variety of water, solvent and distemper based paints.

Walchandnagar Industries: Pune based Walchandnagar Industries to acquire 60.3% shares of Aicitta Intelligent Technology, an unmanned defence systems focused startup. The company will be investing an amount of ₹16 crore in the form of equity shares and compulsorily convertible preference shares.

Ambuja Cements: The Competition Commission of India (CCI) approved the proposal of Ambuja Cements to acquire 72.8 per cent stake in Orient Cement.

Rail Vikas Nigam (RVNL): The company has received a letter of award for ~₹729.8 crore project from Himachal Pradesh Electricity Board. 

Sun TV Network: The company will consider an interim dividend for FY25 on March 7.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here.